Company news

ImmuCell Corporation news in 2026

ImmuCell Corporation's news releases, calls and decks from 2026, newest first.

View company

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2026

November 6, 2026

ImmuCell Announces a 46% Increase in Product Sales in Quarter Three of 2026, Based on Preliminary, Unaudited Sales Results

October 12, 2026

ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2026

August 13, 2026

ImmuCell Announces a 12% Increase in Product Sales in Q2 of 2026 and a 21% Increase in the First Six Months of 2026, Based on Preliminary, Unaudited Sales Results

July 9, 2026

ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2026

May 14, 2026

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2026

May 7, 2026

ImmuCell Bolsters its Innovation Strategy with Appointments of Dr. Gilles Guillemette and Dr. Anthony DiMarco to the Board, and Moves to a Smaller Board of Independent Directors

April 13, 2026

ImmuCell Announces a 28.4% Increase in Product Sales in Q1 of 2026, based on Preliminary, Unaudited Sales Results

April 7, 2026

ImmuCell Appoints Former Elanco Animal Health Board Member Kathy Turner to Board

March 17, 2026

ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2025

March 3, 2026

ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025

February 18, 2026

ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025

January 8, 2026

ImmuCell to Conduct Conference Call with Investors to Discuss Strategic Change in Focus

January 7, 2026

Calls in 2026

Decks in 2026